sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1338.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 15-Jun-2017
PLOS Neglected Tropical Diseases
8 in 10 Indonesian children has been infected with dengue
Indonesia has one of the highest burdens of dengue fever, a mosquito-borne virus, in the world, and children account for many cases. Well over half of all children in urban areas are infected with dengue by the age of 5, and more than 80 percent have been infected with the virus at least once by age 10, researchers now report in PLOS Neglected Tropical Diseases.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 14-Jun-2017
Environmental Research Letters
Temperature changes make it easier for malaria to climb the Ethiopian highlands
The highlands of Ethiopia are home to the majority of the country's population, the cooler climate serving as a natural buffer against malaria transmission. New data now show that increasing temperatures over the past 35 years are eroding this buffer, allowing conditions more favorable for malaria to begin climbing into highland areas.

Contact: Simon Davies
simon.davies@iop.org
44-011-793-01110
IOP Publishing

Public Release: 14-Jun-2017
Cell Host and Microbe
Anti-malaria drugs: Potential new target identified
A newly described protein could be an effective target for combatting drug-resistant malaria parasites. The protein regulates a number of genes involved with a critical part of the parasite's complex life cycle -- its invasion of a person's red blood cells. Now that the researchers know the protein's role in this invasion process, they have a completely new angle for developing new antimalarial drugs for targeting the malaria parasite.
National Institutes of Health, Arnold and Mabel Beckman Foundation, Princeton Center for Quantitative Biology

Contact: Barbara K. Kennedy
bkk1@psu.edu
814-863-4682
Penn State

Public Release: 13-Jun-2017
Science
Argonne X-rays used to help identify a key Lassa virus structure
Research done at Argonne National Laboratory's Advanced Photon Source was vital to the process of identifying the structure, which provides a guide for designing a Lassa virus vaccine. Lassa virus is endemic to Africa and kills thousands of people a year; it is particularly deadly for pregnant women.

Contact: Karen Mellen
kmellen@anl.gov
630-252-5325
DOE/Argonne National Laboratory

Public Release: 13-Jun-2017
PLOS Medicine
US aid to combat malaria in Africa is associated with reduced risk of childhood mortality
In a study published in PLOS Medicine, Aleksandra Jakubowski of the University of North Carolina at Chapel Hill, US, and colleagues show that funding from the US President's Malaria Initiative (PMI) in 19 sub-Saharan African countries was associated with a 16 person reduction in the annual risk of under-five child mortality in the years following introduction of the Initiative.

Contact: Aleksandra Jakubowski
aejaku@unc.edu
PLOS

Public Release: 13-Jun-2017
Genome Research
From Genome Research: Environmental pressures on opportunistic fungal pathogen
With an estimated one million cases diagnosed worldwide each year, the human pathogen Cryptococcus neoformans, which can cause life-threatening fungal infections in immunocompromised patients, is an important health concern. In a study published today in Genome Research, scientists identified natural genomic variation in C. neoformans that may influence prevalence and disease severity.
NIH/National Institute of Allergy and Infectious Diseases, US Public Health Service

Contact: Dana Macciola
macciol@cshl.edu
516-422-4012
Cold Spring Harbor Laboratory

Public Release: 12-Jun-2017
Clinical Infectious Diseases
Pregnancy problems not necessarily tied to Zika viral load or Dengue fever
Researchers have found that Zika viral load and the degree of Zika symptoms during pregnancy were not necessarily associated with problems during pregnancy or fetal abnormalities at birth. They also found that the presence of antibodies to previously acquired dengue fever was not necessarily connected to abnormalities during pregnancy or at birth.
Departamento de Ciência e Tecnologia do Ministério da Saúde do Brasil, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, NIH/National Institute of Allergy and Infectious Diseases, Thrashe

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-267-7120
University of California - Los Angeles Health Sciences

Public Release: 12-Jun-2017
Clinical Infectious Diseases
Low levels of vitamin A may fuel TB risk
People with low levels of vitamin A living with individuals sick with tuberculosis may be 10 times more likely to develop the disease than people with high levels of the nutrient, according to research led by investigators at Harvard Medical School.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ekaterina Pesheva
ekaterina_pesheva@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 12-Jun-2017
GW receives $3 million grant to test hookworm vaccine efficacy in Phase II clinical trial
GW Researchers received a $3 million U01 grant from the National Institutes of Health to test the efficacy of a candidate recombinant hookworm vaccine, the next step in their goal to fight hookworm.
National Institutes of Health

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 11-Jun-2017
The Open Dentistry Journal
Chemical composition and microhardness of human enamel treated with fluoridated whintening agents
Aesthetic treatments are always widely sought by dental patients, especially dental whitening, in order to get whiter smiles. The big demand for this type of procedure raises the concern in the dental research community that this type of treatment has the potential to make dental alterations that cause damage to the dental structure and if there are suitable components that can be added to dental bleaching agents to reduce such effects.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 8-Jun-2017
International Journal of Economics and Business Research
Cost-effectiveness of HIV/AIDS interventions in South Africa
An international African collaboration has turned to statistical analysis to determine the cost effectiveness of major HIV/AIDS interventions in South Africa with a view to advising policy makers on the optimal approach to managing the disease. Details are reported this month in the International Journal of Economics and Business Research.

Contact: Albert Ang
press@inderscience.com
Inderscience Publishers

Public Release: 8-Jun-2017
Nature Communications
Investigational vaccine protected monkeys from HIV-like virus
Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.
Center for HIV/AIDS Vaccine Immunology, NIH/National Institute of Allergy and Infectious Diseases, Bill & Melinda Gates Foundation

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 8-Jun-2017
PLOS Neglected Tropical Diseases
Sanitation access linked to children's growth and health
An estimated 1 billion people in the world live without access to any type of sanitation facility, such as a toilet or latrine. Sanitation access is known to be associated with the risk of transmitting certain diseases, including parasitic worms. But the impacts don't stop there. For children, living in a community with poor levels of sanitation access increases their odds of stunted growth, anemia, and diarrhea, even if their household has access to a sanitation facility researchers report in PLOS Neglected Tropical Diseases.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 7-Jun-2017
European Journal of Preventive Cardiology
Running multiple marathons does not increase risk of atherosclerosis
Running multiple marathons does not increase the risk of atherosclerosis, according to research published today in the European Journal of Preventive Cardiology.
EnzyMagic Trial, MUCOS Pharma

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 7-Jun-2017
Pediatrics
Eggs can significantly increase growth in young children
Eggs significantly increased growth and reduced stunting by 47 percent in young children, finds a new study from a leading expert on child nutrition at the Brown School at Washington University in St. Louis. This was a much greater effect than had been shown in previous studies.
The Mathile Institute for the Advancement of Human Nutrition

Contact: Neil Schoenherr
nschoenherr@wustl.edu
314-935-5235
Washington University in St. Louis

Public Release: 2-Jun-2017
Science
Details of Lassa virus structure could inform development of vaccines, therapies
A 10-year Lassa virus research project has yielded structural and functional details of a key viral surface protein that could help advance development of Lassa vaccines and antibody-based therapeutics, which are currently lacking. The work was led by the Scripps Research Institute (TSRI) and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Jun-2017
Clinical Pediatrics
Telehealth reduces wait time, improves care for children with autism living in remote areas
Kristin Sohl, director of ECHO Autism, says that the expanding ECHO Autism will help families and children with autism around the world, especially those living in remote areas.

Contact: Sheena Rice
RiceSM@missouri.edu
573-882-8353
University of Missouri-Columbia

Public Release: 1-Jun-2017
International Journal of Paleopathology
Why was a teenager with bone cancer buried on Witch Hill in Panama?
Likely the first bone tumor from an ancient skeleton in Central America is reported by Smithsonian archaeologists and colleagues. The starburst-shaped tumor is in the upper right arm of the skeleton of an adolescent buried in about 1300 AD in a trash heap at a site in western Panama called Cerro Brujo or Witch Hill. The reason for what appears to be a ritual burial in this abandoned pre-Colombian settlement is unknown.
Smithsonian Tropical Research Institute, National Science Foundation

Contact: Beth King
kingb@si.edu
20-263-347-002-8216
Smithsonian Tropical Research Institute

Public Release: 1-Jun-2017
Geospatial Health
How to attack Africa's neonatal mortality problem
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa -- a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.

Contact: Andy Henion
henion@msu.edu
517-355-3294
Michigan State University

Public Release: 1-Jun-2017
Science
Perseverance pays off in fight against deadly Lassa virus
This story starts with a young graduate student in San Diego and leads all the way to Sierra Leone, to a unique hospital where Lassa fever victims arrive by the thousands every year.
National Institutes of Health, Burroughs Wellcome Fund

Contact: Madeline McCurry-Schmidt
madms@scripps.edu
858-784-9254
Scripps Research Institute

Public Release: 1-Jun-2017
PLOS Neglected Tropical Diseases
Elephantiasis patients more likely to have depression
Many patients infected with filarial worms have no symptoms, but those who develop disfiguring lymphatic filariasis -- more commonly known as elephantiasis -- often struggle with discrimination and rejection. Now, researchers have quantified that burden, reporting in PLOS Neglected Tropical Diseases that lymphatic filariasis patients in Nigeria have about four times the rate of depression as other adults there.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 31-May-2017
Nature
Progress reported in global fight against diarrheal disease cryptosporidiosis
Infectious disease scientists from Novartis, the University of Georgia and Washington State University have reported the discovery and early validation of a drug candidate for treating cryptosporidiosis, a diarrheal disease which is a major cause of child mortality in lower-income countries. Currently there are no vaccines or effective treatments.
Novartis Institutes for Biomedical Research, Wellcome Trust, National Institutes of Health, Medicines for Malaria Venture

Contact: Sandra Schluechter
sandra.schluechter@novartis.com
Novartis Institutes for BioMedical Research

Public Release: 30-May-2017
Antimicrobial Agents and Chemotherapy
Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment
New research suggests the bacteria that cause tuberculosis alter their metabolism to combat exposure to antimicrobials, and that these metabolic 'escape pathways' might be neutralized by new drugs to shorten the troublesome duration of therapy.
National Institutes of Health

Contact: Luiz Bermudez
Luiz.Bermudez@oregonstate.edu
541-737-6532
Oregon State University

Public Release: 30-May-2017
Radboudumc, iMM Lisboa, PATH collaborate on first-in-human study of novel malaria vaccine
The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH in Seattle, Wash., announced today that they will collaborate to test a new approach to malaria vaccine development in humans for the first time.

Contact: Ana de Barros
anabarros@medicina.ulisboa.pt
003-519-120-31867
Instituto de Medicina Molecular

Public Release: 30-May-2017
PLOS Biology
Mosquitoes infected with virus-suppressing bacteria could help control dengue fever
Mosquitoes infected with the bacteria Wolbachia are significantly worse vectors for dengue virus, but how to establish and spread Wolbachia in an urban mosquito population is unclear. A study publishing on May 30, 2017, in the open-access journal PLOS Biology by Michael Turelli from University of California, Davis, and colleagues from Scott O'Neill's 'Eliminate Dengue Program' demonstrates that over time, strategic releases may be enough for mosquitoes infected with the dengue-suppressing bacteria to spread across large cities.

Contact: Michael Turelli
mturelli@ucdavis.edu
PLOS

Showing releases 26-50 out of 1338.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>